Industry
SONN’s Financial Health: Exploring Sonnet BioTherapeutics Holdings Inc’s Debt-to-Equity Ratio of 1.79
Sonnet BioTherapeutics Holdings Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $18.72 on 03/18/24, with the lowest value being $4.00 on 11/04/24. 52-week price history of SONN Stock Analyzing the 52-week price history of a
